Published in Am J Public Health on January 01, 2001
Risk factors for hepatitis C virus infection among homeless adults. J Gen Intern Med (2002) 1.46
Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med (2004) 1.41
Impact of a positive hepatitis C diagnosis on homeless injecting drug users: a qualitative study. Br J Gen Pract (2005) 1.28
Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users. Public Health Rep (2002) 1.13
A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users. Harm Reduct J (2006) 1.01
Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health (2001) 4.57
Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health (2001) 3.46
Natural history of hepatitis C. Hepatology (1997) 2.63
Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. Am J Public Health (2001) 2.02
The importance of preventing hepatitis C virus infection among injection drug users in the United States. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.68
Hepatitis C virus transmission dynamics in injection drug users. Subst Use Misuse (1998) 1.51
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med (2000) 8.05
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med (2000) 6.58
A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med (1993) 6.18
Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. JAMA (2001) 4.90
The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis (1999) 4.37
Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA (1995) 3.64
Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ (1992) 3.57
Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J Infect Dis (1998) 3.18
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09
Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA (1991) 3.09
Reduction in the incidence of human listeriosis in the United States. Effectiveness of prevention efforts? The Listeriosis Study Group. JAMA (1995) 2.97
Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis (1996) 2.85
Risk factors for group B streptococcal disease in adults. Ann Intern Med (1995) 2.78
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health (2000) 2.57
Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis (1999) 2.57
Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. The Listeria Study Group. JAMA (1992) 2.15
The 1997 AAP guidelines for prevention of early-onset group B streptococcal disease. American Academy of Pediatrics. Pediatrics (1997) 2.04
The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol (1996) 1.99
Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96. Bull World Health Organ (1999) 1.96
Comparison of ribotyping and multilocus enzyme electrophoresis for subtyping of Listeria monocytogenes isolates. J Clin Microbiol (1994) 1.96
Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nat Med (1999) 1.92
Meningococcal disease in Los Angeles County, California, and among men in the county jails. N Engl J Med (1996) 1.89
Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clin Infect Dis (2002) 1.84
The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. J Infect Dis (2000) 1.69
Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis. JAMA (1993) 1.63
Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization. Am J Obstet Gynecol (2001) 1.51
Prevention of perinatal group B streptococcal infection: current controversies. Obstet Gynecol (2000) 1.46
Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa. Bull World Health Organ (2006) 1.41
Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J (1998) 1.39
A foodborne outbreak of gastroenteritis involving Listeria monocytogenes. Epidemiol Infect (1996) 1.37
Outbreaks of salmonellosis associated with eating uncooked tomatoes: implications for public health. The Investigation Team. Epidemiol Infect (1999) 1.36
Toxic shock syndrome in the United States: surveillance update, 1979 1996. Emerg Infect Dis (2000) 1.35
Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics (2001) 1.35
Invasive group B streptococcal disease in Maryland nursing home residents. J Infect Dis (2001) 1.31
School-based clusters of meningococcal disease in the United States. Descriptive epidemiology and a case-control analysis. JAMA (1997) 1.28
Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. Arch Intern Med (2000) 1.26
Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine. Infect Immun (1998) 1.25
Epidemic nephritis in Nova Serrana, Brazil. Lancet (2000) 1.19
Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelines. The Active Bacterial Core Surveillance Team. Obstet Gynecol (2000) 1.17
Increased risk of meningitis and bacteremia due to Listeria monocytogenes in patients with human immunodeficiency virus infection. Clin Infect Dis (1993) 1.15
A multistate outbreak of sporotrichosis associated with sphagnum moss. Am J Epidemiol (1992) 1.11
Estimating the vaccine-preventable burden of hospitalized pneumonia among young Mozambican children. Vaccine (2010) 1.09
Gastrointestinal carriage of Listeria monocytogenes in household contacts of patients with listeriosis. J Infect Dis (1993) 1.07
Haemophilus influenzae type B infection. Bull World Health Organ (1998) 1.07
Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger. Pediatr Infect Dis J (2000) 1.05
Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience. Vaccine (2010) 1.04
Should college students be vaccinated against meningococcal disease? A cost-benefit analysis. Am J Public Health (1995) 1.03
Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis (2001) 1.00
Decline in sepsis-associated neonatal and infant deaths in the United States, 1979 through 1994. Pediatrics (1998) 0.99
Epidemiology of pneumococcal infections in the elderly. Drugs Aging (1999) 0.99
Neonatal group B streptococcal disease--screening and prevention. N Engl J Med (2000) 0.98
Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clin Infect Dis (2000) 0.98
Listeria monocytogenes CAMP reaction. Clin Microbiol Rev (1991) 0.97
Response to conjugate Haemophilus influenzae B vaccine among infants in Niamey, Niger. Am J Trop Med Hyg (1998) 0.97
Comparison of cold enrichment and U.S. Department of Agriculture methods for isolating Listeria monocytogenes from naturally contaminated foods. The Listeria Study Group. Appl Environ Microbiol (1991) 0.96
Prevention practices for perinatal group B streptococcal disease: a multi-state surveillance analysis. Neonatal Group B Streptococcal Disease Study Group. Obstet Gynecol (1997) 0.93
Invasive pneumococcal infection in Baltimore, Md: implications for immunization policy. Arch Intern Med (2000) 0.91
Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States. Vaccine (2001) 0.91
Neonatal group B streptococcal disease: how infection control teams can contribute to prevention efforts. Infect Control Hosp Epidemiol (2000) 0.89
Association between colonization with group B streptococci during pregnancy and preterm delivery among Danish women. Am J Obstet Gynecol (2001) 0.88
Physicians' prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions. CMAJ (2001) 0.87
1997 AAP guidelines for prevention of early-onset group B streptococcal disease. Pediatrics (1999) 0.86
Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. The Neonatal Group B Streptococcal Disease Study Group. Obstet Gynecol (1997) 0.83
Impact of a risk-based prevention policy on neonatal group B streptococcal disease. Am J Obstet Gynecol (1998) 0.81
Outbreak of early onset group B streptococcal sepsis. Pediatr Infect Dis J (1993) 0.80
Immunogenicity, safety, and memory of different schedules of Neisseria meningitidis A/C-diphtheria toxoid conjugate vaccine in infants in Niger. Vaccine (2004) 0.80
Group B streptococcal disease prevention practices of obstetrician-gynecologists. Obstet Gynecol (2001) 0.79
Barriers to prevention of perinatal group B streptococcal disease. Pediatr Infect Dis J (1995) 0.78
Listeriosis and pregnancy: food for thought. Obstet Gynecol Surv (1997) 0.78
Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States. J Infect Dis (2003) 0.78
Reporting of toxic shock syndrome. J Infect Dis (1992) 0.75
Meningococcal vaccine in sub-Saharan Africa. Lancet (1997) 0.75
Ethical issues associated with routine screening and prophylaxis for group B streptococcus in pregnancy. Infect Dis Obstet Gynecol (1996) 0.75
Microbes without borders: infectious disease, public health, and the journal. Am J Public Health (2000) 0.75
Hospital, heal thyself. Am J Public Health (1997) 0.75
The pediatric costs of strategies for minimizing the risk of early-onset group B streptococcal disease. Obstet Gynecol (1998) 0.75
Human methane production: a study of population groups and environmental factors in Israel. Isr J Med Sci (1986) 0.75
Prevention of perinatal group B streptococcal infections. Pediatr Infect Dis J (1999) 0.75